BioCryst Pharmaceuticals Market Cap

BioCryst Pharmaceuticals has a market cap or net worth of 26.83 billion as of February 10, 2026. Its market cap has decreased by -16.14% in one year.

Market Cap

26.83B

Enterprise Value

34.91B

Revenue

11.00B

Ranking

n/a

PE Ratio

n/a

Stock Price

118.00

Market Cap Chart

Since March 4, 1994, BioCryst Pharmaceuticals's market cap has increased from 69.93M to 26.83B, an increase of 38,272.01%. That is a compound annual growth rate of 20.46%.

Market Cap History

Date	Market Cap	% Change
Feb 9, 2026	26.83B	-9.25%
Dec 31, 2025	29.57B	-8.91%
Dec 31, 2024	32.46B	56.49%
Dec 29, 2023	20.74B	-50.32%
Dec 30, 2022	41.75B	-18.29%
Dec 31, 2021	51.09B	95.19%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Grupo Profuturo	35.29B
Grupo Lamosa	35.02B
Fibra Mty, S.A.P.I. de C.V.	34.96B
FIBRA Terrafina	34.15B
Grupo Gigante, S. A. B. de C. V.	30.62B
FIBRA Macquarie México	29.40B
Grupo Nacional Provincial, S.A.B.	26.85B
Fideicomiso Irrevocable Numero Cib/2919 (Cfe Fibra E)	26.51B

Market Cap Rankings